These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 11365531)

  • 21. Malignancies in HIV: the Indian scenario.
    Dhir AA; Sawant SP
    Curr Opin Oncol; 2008 Sep; 20(5):517-21. PubMed ID: 19106653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten years later: a single hospital experience with malignancy in HIV/AIDS.
    Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E
    J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
    Chaturvedi AK; Mbulaiteye SM; Engels EA
    Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future.
    Engels EA; Goedert JJ
    J Natl Cancer Inst; 2005 Mar; 97(6):407-9. PubMed ID: 15769998
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AIDS related malignant disease at regional institute of medical sciences.
    Gatphoh ED; Zamzachin G; Devi SB; Punyabati P
    Indian J Pathol Microbiol; 2001 Jan; 44(1):1-4. PubMed ID: 12561985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AIDS-related cancers in the era of highly active antiretroviral therapy.
    Biggar RJ
    Oncology (Williston Park); 2001 Apr; 15(4):439-48; discussion 448-9. PubMed ID: 11346932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphoma.
    Clayton G; Omasta-Martin A; Bower M
    J HIV Ther; 2006 Sep; 11(3):51-3. PubMed ID: 17580498
    [No Abstract]   [Full Text] [Related]  

  • 30. AIDS malignancies 1999: a tale of three viruses.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1999 Aug; 5(8):22-7, 32-8. PubMed ID: 11367308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The trouble with tumors.
    Dawson D
    STEP Perspect; 1999; 99(1):8-9. PubMed ID: 11367167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G; Barbarini G
    Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
    Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
    J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
    International Collaboration on HIV and Cancer
    J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
    Cingolani A; Fratino L; Scoppettuolo G; Antinori A
    J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographical patterns of Kaposi's sarcoma, nonHodgkin lymphomas, and cervical cancer associated with HIV infection in five African populations.
    Chaabna K; Boniol M; de Vuyst H; Vanhems P; Antônio de Ávila Vitoria M; Curado MP
    Eur J Cancer Prev; 2012 Jan; 21(1):1-9. PubMed ID: 21955799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AIDS cancers: conundrums and controversies.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):10-30. PubMed ID: 11364711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of HAART on HIV-linked malignancies.
    Laurence J
    AIDS Read; 2003 May; 13(5):202, 205. PubMed ID: 12800820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.